QUOTED. 7 April 2020. Surendar Magar.
Executive Summary
California-based biosensor patch company LifeSignals Group plans to file for an emergency use authorization from the US FDA for a new patch that can monitor vital signs to help individuals decide when to seek the help of a health care provider. See what LifeSignals’ CEO Surendar Magar said about it here.
“A lot of people are very anxious and some people may not know when to go and see the doctor, so the whole idea is to give consumers the guidance and give some comfort that they are being watched.” – Surendar Magar, CEO, LifeSignals
- Find out more: LifeSignals Plans to Market Biosensor Patch To Help Consumer Identify COVID-19 Symptoms
Click here for a free trial of Medtech Insight